Advertisement

Advertisement

Op-Ed

Advertisement

Advertisement



Feb
18
Today In Oncology
CMS Proposes Medicare Coverage With Evidence Development for CAR T-Cell Therapy
FDA Pipeline: Priority Reviews in Renal Cell Carcinoma and Head and Neck Cancer
First-Line Pembrolizumab in Advanced Merkel Cell Carcinoma
Gastric Acid Suppressants May Reduce Survival Outcomes in Patients With Sarcoma Treated With Pazopanib
New Approach to Predicting Response to Pertuzumab and Trastuzumab in Breast Cancer
View More 
;
Advertisement
Most Read Stories
Selected Abstracts From the San Antonio Breast Cancer Symposium
New Approach to Predicting Response to Pertuzumab and Trastuzumab in Breast Cancer
Novel Treatments of Myelodysplastic Syndromes
KEYNOTE-181: Pembrolizumab vs Chemotherapy in Second-Line Treatment of Advanced Esophageal Cancer
Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects
View More 
Most Viewed Videos
Katherine C. Lee, MD, on Emergency Surgery and End-of-Life Care
Facing Death: Having the Difficult Conversation With Your Patients
Eva M. Ciruelos, MD, PhD, on HER2-Positive Breast Cancer: Results From the PATRICIA Trial
Jonathan R. Strosberg, MD, on Neuroendocrine Tumors: Results From the KEYNOTE-158 Trial on PD-1 Inhibition
John G. Gribben, MD, DSc, on The Tumor Microenvironment, Prognosis, and Outcome
View More 
© 2019 HSP News Service, L.L.C.